GV 2019 GP, L.L.C.

CIK 1845038 · last filed 2026-05-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$185.54M

Companies

4

Total Filings

21

Lifetime Open-Market Net

-$103.38M

Filer Profile

Reported Address
1600 AMPHITHEATRE PKWY
MOUNTAIN VIEW, CA 94043
Phone
(650) 335-5278
State of Incorporation
DE
Related Filers
GV 2019 GP, L.P. — 36 joint filings, latest 2026-07-29
GV 2019, L.P. — 36 joint filings, latest 2026-07-29
Alphabet Inc. — 31 joint filings, latest 2026-07-29
GV 2021 GP, L.L.C. — 25 joint filings, latest 2026-07-29
GV 2021 GP, L.P. — 25 joint filings, latest 2026-07-29
GV 2021, L.P. — 25 joint filings, latest 2026-07-29
GV 2017 GP, L.L.C. — 6 joint filings, latest 2026-01-30
GV 2017 GP, L.P. — 6 joint filings, latest 2026-01-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GOOGL 10%+ Owner 0 $343.92 $0 -$23.47M 16 2026-05-18
PRME 10%+ Owner 10,557,092 $2.90 $30.62M -$13.23M 1 2023-05-24
Verve Therapeutics, Inc. (VERV) Delisted 10%+ Owner 4,260,940 $11.13 $47.42M -$66.69M 3 2022-11-08
IONQ.WS 4,556,532 $34.00 $154.92M $0 1 2022-04-12

Recent Filings · Page 2 of 3

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-05-24 PRME Mixed −1,846,054 -$13.23M EDGAR
2023-05-24 GOOGL Mixed −263,722 -$1.89M EDGAR
2023-05-22 GOOGL Mixed −167,544 -$1.23M EDGAR
2023-05-18 GOOGL Sell (S) −65,649 -$829.3K EDGAR
2023-05-16 GOOGL Sell (S) −185,242 -$2.36M EDGAR
2023-05-12 GOOGL Sell (S) −114,023 -$1.58M EDGAR
2023-05-10 GOOGL Sell (S) −422,010 -$5.95M EDGAR
2022-11-08 Verve Therapeutics, Inc. (VERV) Delisted Mixed −1,020,243 -$21.18M EDGAR
2022-11-02 Verve Therapeutics, Inc. (VERV) Delisted Mixed −1,798,853 -$45.51M EDGAR
2022-04-12 IONQ.WS — — $0 EDGAR
Showing 11–20 of 21
Page 2 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.